Investing Ideas
/
Egyptian Pharmaceuticals & Biotech Content Is King

Header cover image

Egyptian Pharmaceuticals & Biotech Content Is King

UPDATED Mar 13, 2024

Online and offline publishers of content.

11 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	PHAR Egyptian International Pharmaceutical Industries	ج.م48.87	3.8%	47.9%	ج.م7.2b	ج.م72.20	PE8.8x	E14.2%	2.0%
	RMDA Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda)E	ج.م2.62	-5.1%	98.5%	ج.م4.0b	ج.م3.09	PE17.3x	E27.5%	n/a
	BIOC GlaxoSmithKlineE	ج.م33.16	-8.5%	30.3%	ج.م2.9b	n/a	PE37.4x	n/a	2.3%
	MIPH MINAPHARM Pharmaceuticals	ج.م260.00	2.3%	35.0%	ج.م2.9b	n/a	PE6.2x	n/a	1.1%
	AXPH Alexandria For Pharmaceuticals & Chemical Industries	ج.م232.10	-3.6%	70.7%	ج.م1.2b	n/a	PE7.7x	n/a	5.6%
	OCPH October PharmaE	ج.م100.00	0%	0%	ج.م1.2b	n/a	PE10.5x	n/a	1.5%
	CPCI Kahira Pharmaceuticals & Chemical Industries	ج.م78.45	0%	121.3%	ج.م1.2b	n/a	PE10x	n/a	6.4%
	NIPH Nile for Pharmaceuticals and Chemical Industries	ج.م88.25	0%	145.1%	ج.م893.5m	n/a	PE9.5x	n/a	5.7%
	MPCI Memphis Pharmaceuticals & Chemical Industries	ج.م100.32	-13.5%	283.3%	ج.م638.2m	n/a	PE6.4x	n/a	2.0%
	ADCI Arab Drug	ج.م84.73	-2.7%	32.4%	ج.م522.2m	n/a	PE6.8x	n/a	5.3%
	SIPC Sabaa International Company for Pharmaceutical and Chemical Industry	ج.م0.76	0.3%	-24.1%	ج.م190.0m	n/a	PE123.7x	n/a	0%

Page 1 of 1